Client success story
Drug Discovery Platform Roadmap
Business Value: Accelerating Discovery with Optimized Informatics Systems
Summary: Streamlining Drug Discovery with Improved Technology
bPrescient created a plan and roadmap to consolidate data platforms in a small-molecule drug discovery organization, providing leadership with timelines and resource estimates so that the benefits and cost could be well understood.
Challenge: Fragmented Informatics Architecture Delays Discovery
This growing company was looking to improve their ability to track, manage, and analyze the data associated with their screening and validation efforts. They had a variety of informatics systems, including multiple ELNs, across multiple sites, which caused inefficiencies and miscommunications in their discovery workflows. Without upgrading their informatics infrastructure, they risked missing key discoveries and being slow to react to new methods and information.
Solution: Research Informatics Roadmap & Strategy
bPrescient developed a Research Informatics Roadmap and Strategy that addressed these challenges by documenting key workflows, identifying gaps in current systems, and assessing platform options that set the stage for growth. The Roadmap and Strategy included documentation of the existing systems, recommendations for new and updated systems, and a roadmap for bringing those new systems on board.
Outcome: Confidence in Next Steps to Accelerate Discovery
The company received a roadmap and strategy that contained timelines, milestones, implementation options, and resource estimates. With this information, the company was able to make a confident decision in choosing Dotmatics as their primary discovery platform and quickly transitioned into the implementation phase.
Let’s talk
Tell us about your toughest R&D challenge and let’s discuss how bPrescient can solve it.
